Suppr超能文献

[地方性甲状腺肿区域的甲状腺分化癌。临床研究及预后相关性]

[Differentiated carcinoma of the thyroid gland in an area of endemic goiter. Clinical study and prognostic correlation].

作者信息

Mato A, Gippini A, Peino R, Gayoso P, Uriel B

机构信息

Sección de Endocrinología, Residencia Sanitaria Virgen del Cristal, Servicio Gallego de Salud, Orense.

出版信息

An Med Interna. 1996 Nov;13(11):537-40.

PMID:9019212
Abstract

OBJECTIVE

Differentiated thyroid Carcinoma is a relatively frequent malignant neoplasia with three histologic types: papillary, follicular, and Hürtle cell carcinoma. Although papillary is the most common type, in endemic goitre areas the frequency of follicular type increases. Up to now, the only European studies about clinical aspects of differentiated thyroid carcinoma in endemic goitre areas are those performed in the Bavarian region until 1983. As the province of Orense (assistance zone concerning to the Hospital Virgen del Cristal) is a zone of endemic goitre, we have analyzed clinical presentation features and prognostic correlation factors in patients with differentiated thyroid carcinoma living in this area.

DESIGN

Retrospective study. Variables analyzed: 1) Age. 2) Sex. 3) Histologic type. 4) Tumor size. 5) Stage. 6) Presence of multinodular goitre. 7) Posttherapeutic disease persistence. 8) Recurrence. 9) Distant metastases. 10) Death attributed to thyroid carcinoma.

PATIENTS

61 cases of differentiated thyroid carcinoma, detected from 1983 to 1993. Mean follow-up period: 5 years (minimum 1, maximum 21). All patients were treated with total thyroidectomy followed by radioiodine ablation.

RESULTS

67.2% of papillary, 31.2% of follicular and 1.6% of Hürtle cell carcinoma. Male/female ratio: 1/4. Mean age: 48.8 +/- 2.9 (M +/- ESM) in papillary and 55 +/- 3.2 in follicular. Tumor size was smaller in papillary: 2.2 +/- 0.2 vs 6.2 +/- 0.5 cm (p < 0.001). Papillary type was detected more frequently than follicular in stages I, II and III, whereas follicular prevailed in stage IV (p < 0.03). Positive correlation between age and size in papillary: r = 0.393 (p < 0.01) and similar tendency in follicular: r = 0.423 (p = 0.057). Multinodular goitre was more frequent in follicular: 47% vs 25% (p = 0.02). Free of disease cases after treatment: 81% of papillary (p < 0.05) and 42% of follicular. Stage correlated independently with disease persistence after treatment (p = 0.0006). Age was minor in free of disease group: 50.0 +/- 3.8 vs 65.3 +/- 3.8 (p = 0.01).

CONCLUSIONS

In our area, papillary is the most common type, but follicular proportion is higher than reported from non endemic goitre areas. PC is a small tumor detected in stage I, whereas FC is large and detected in stage IV. Tumor stage is an independent prognostic factor. Frequent presence of multinodular goitre in patients with differentiated thyroid carcinoma suggests that in zones of endemic goitre, clinical attitude in multinodular goitre and solitary nodule must be similar.

摘要

目的

分化型甲状腺癌是一种相对常见的恶性肿瘤,有三种组织学类型:乳头状癌、滤泡状癌和许特耳细胞癌。虽然乳头状癌是最常见的类型,但在地方性甲状腺肿地区,滤泡状癌的发病率会增加。到目前为止,欧洲关于地方性甲状腺肿地区分化型甲状腺癌临床方面的研究,仅有1983年以前在巴伐利亚地区开展的那些。由于奥伦塞省(维琴德尔克里斯塔尔医院的服务区域)是一个地方性甲状腺肿地区,我们分析了该地区分化型甲状腺癌患者的临床表现特征及预后相关因素。

设计

回顾性研究。分析的变量:1)年龄。2)性别。3)组织学类型。4)肿瘤大小。5)分期。6)多结节性甲状腺肿的存在情况。7)治疗后疾病持续存在情况。8)复发。9)远处转移。10)甲状腺癌所致死亡。

患者

1983年至1993年间检测出的61例分化型甲状腺癌患者。平均随访期:5年(最短1年,最长21年)。所有患者均接受了甲状腺全切术,随后进行放射性碘消融治疗。

结果

乳头状癌占67.2%,滤泡状癌占31.2%,许特耳细胞癌占1.6%。男女比例为1/4。乳头状癌患者的平均年龄为48.8±2.9(均值±标准误),滤泡状癌患者为55±3.2。乳头状癌的肿瘤较小:2.2±0.2厘米对6.2±0.5厘米(p<0.001)。在Ⅰ期、Ⅱ期和Ⅲ期,乳头状癌的检出频率高于滤泡状癌,而在Ⅳ期滤泡状癌占优势(p<0.03)。乳头状癌中年龄与大小呈正相关:r = 0.393(p<0.01),滤泡状癌也有类似趋势:r = 0.423(p = 0.057)。滤泡状癌患者多结节性甲状腺肿更为常见:47%对25%(p = 0.02)。治疗后无疾病病例:乳头状癌为81%(p<0.05),滤泡状癌为42%。分期与治疗后疾病持续存在独立相关(p = 0.0006)。无疾病组的年龄较小:50.0±3.8对65.3±3.8(p = 0.01)。

结论

在我们地区,乳头状癌是最常见的类型,但滤泡状癌的比例高于非地方性甲状腺肿地区的报道。乳头状癌是在Ⅰ期检测出的小肿瘤,而滤泡状癌较大且在Ⅳ期检测出。肿瘤分期是一个独立的预后因素。分化型甲状腺癌患者中多结节性甲状腺肿常见,这表明在地方性甲状腺肿地区,对多结节性甲状腺肿和孤立性结节的临床处理态度必须相似。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验